" "
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sysmex America to Spotlight the Future of Hematology Technology During AACC

Published: Tuesday, July 17, 2012
Last Updated: Tuesday, July 17, 2012
Bookmark and Share
Company to showcase new hematology and urinalysis instruments that will represent 80% of the company's future product offering during this week's American Association of Clinical Chemistry (AACC) meeting in Los Angeles.

All of the new instruments are pending FDA 510(k) clearance and are not yet available for sale in the U.S. WAM Select(TM), a new middleware software offering that enables efficiency and control over hematology workflow and results management for small to medium-sized clinical laboratories also will be exhibited. The above instruments and software and cell imaging products can be found at Sysmex's exhibit booth #1347. Sysmex is a global leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems and services hospitals and healthcare networks, reference laboratories and physicians offices worldwide.

Sysmex in-booth educational presentations, which will feature topics about hematology technology, diabetes management and advanced clinical parameters, among others, are as follows:

Actionable Management Reports: Put Yourself in the Driver's Seat Now!Anne Tate, MT(ASCP)SC, Senior Product Manager, IT Products, Sysmex America, Inc., Mundelein, IL

HbA1c: The Roadmap to Successful Management of the Diabetic PatientMichael Spiekerman M.D., Professor of Pathology and Laboratory Medicines, Texas A&M Health Science Center College of Medicine, Chief, Section of Chemistry Clinical Pathology, Scott & White Healthcare, Temple, TX

Even Small Labs Deserve Auto-validation (WAM Select)Julia Witt, SH(ASCP), Hematology Supervisor - Smith-Glynn-Callaway, Mercy Clinic Laboratory Services, Springfield, MO

Quick Tools to Measure Hematology Lab Productivity and Turn-around TimesAllen A. Wozniak, Sr., MT(ASCP) SC, Sr. Laboratory Consultant, Sysmex America, Inc., Mundelein, IL

The Future of Hematology Technology - Sysmex XN Series*Barbara Connell, MS, MT(ASCP)SH, Sr. Manager, Scientific Marketing, Sysmex America, Inc., Mundelein, IL*Pending FDA 510(k) clearance, not available for sale in the US.

The Measurement of Immature Cells in the Peripheral Blood - A Window to Bone Marrow AssessmentJennifer Marcenelle, RN, MBA, Manager, Clinical Support, Sysmex America, Inc., Mundelein, IL

Sysmex: Shaping the Future of Laboratory ServicesJackie Guenther, MT(ASCP), Sr. Product Manager, Service Marketing, Sysmex America, Inc., Mundelein, IL

Sysmex associates from the U.S., Canada and Latin America will be available to speak with clinical laboratory professionals about the Sysmex hematology and urinalysis instruments, middleware and cell image analysis products at the Sysmex booth #1347.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!